CANNAPHARMARX, INC. Cash and Restricted Cash
CANNAPHARMARX, INC. (CPMD) had Cash and Restricted Cash of $555 as of 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-18
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $555.00.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $633.00.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.80K.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $927.00.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $555.00 10-Q · filed 2026-08-18 |
| 2026-03-31 | $633.00 10-Q · filed 2026-05-20 |
| 2025-12-31 | $1.80K 10-Q · filed 2026-08-18 |
| 2025-09-30 | $927.00 10-Q · filed 2025-11-14 |
| 2025-06-30 | $16.98K 10-Q · filed 2026-08-18 |
| 2025-03-31 | $1.21K 10-Q · filed 2026-05-20 |
| 2024-12-31 | $2.16K 10-Q · filed 2026-08-18 |
| 2024-09-30 | $7.00K 10-Q · filed 2025-11-14 |
| 2024-06-30 | $9.14K 10-Q · filed 2025-08-14 |
| 2024-03-31 | $12.09K 10-Q · filed 2025-05-16 |
| 2023-12-31 | $650.00 10-K · filed 2026-03-31 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 |
| 2023-06-30 | $0.00 10-Q · filed 2023-10-13 |
| 2023-03-31 | $0.00 10-Q · filed 2024-06-25 |
| 2022-12-31 | $2.32K 10-K · filed 2025-04-10 |
| 2022-09-30 | $7.50K 10-Q · filed 2023-11-17 |
| 2022-06-30 | $5.18K 10-Q · filed 2023-10-13 |
| 2022-03-31 | $79.68K 10-Q · filed 2023-09-22 |
| 2021-12-31 | $27.77K 10-Q · filed 2023-11-17 |
| 2021-09-30 | $112.82K 10-Q · filed 2022-11-21 |
| 2021-06-30 | $110.16K 10-Q · filed 2022-08-22 |
| 2021-03-31 | $30.08K 10-Q · filed 2022-05-23 |
| 2020-12-31 | $334.97K 10-K · filed 2023-09-01 |
| 2019-12-31 | $1.55K 10-K · filed 2022-04-15 |